{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:31:33Z","timestamp":1792477893719,"version":"4.5.0"},"reference-count":130,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:00:00Z","timestamp":1650153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM138682"],"award-info":[{"award-number":["R01GM138682"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Coccidioidomycosis, also known as Valley fever, is an endemic fungal infection commonly found in the southwestern parts of the United States. However, the disease has seen an increase in both in its area of residency and its prevalence. This review compiles some of the latest information on the epidemiology, current and in-development pharmaceutical approaches to treat the disease, trends and projections, diagnostic concerns, and the overlapping dynamics of coccidioidomycosis and COVID-19, including in special populations. This review provides an overview of the current diagnostic and therapeutic strategies and identifies areas of future development.<\/jats:p>","DOI":"10.3390\/jof8040413","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T04:21:28Z","timestamp":1650255688000},"page":"413","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Current Landscape of Coccidioidomycosis"],"prefix":"10.3390","volume":"8","author":[{"given":"Ryan","family":"Boro","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prema C.","family":"Iyer","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-0817","authenticated-orcid":false,"given":"Maciej A.","family":"Walczak","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Colorado, Boulder, CO 80309, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,17]]},"reference":[{"key":"ref_1","first-page":"185","article-title":"Coccidioidomycosis: Epidemiology","volume":"5","author":"Brown","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/02664763.2020.1825646","article-title":"A non-parametric Hawkes model of the spread of Ebola in west Africa","volume":"49","author":"Park","year":"2020","journal-title":"J. Appl. Stat."},{"key":"ref_3","first-page":"585","article-title":"Un nuevo caso de micosis fungoidea con posrospemias","volume":"15","author":"Posadas","year":"1892","journal-title":"Ann. Cir. Med. Argent"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15572536.2003.11833250","article-title":"Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis","volume":"94","author":"Fisher","year":"2002","journal-title":"Mycologia"},{"key":"ref_5","first-page":"2333794x20969282","article-title":"Update on Coccidioidomycosis in the United States and Beyond","volume":"7","author":"Bajwa","year":"2020","journal-title":"Glob. Pediatr. Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/mmy\/myy037","article-title":"Coccidioidomycosis in Latin America","volume":"57","author":"Arathoon","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e20200249","DOI":"10.1590\/0037-8682-0249-2020","article-title":"Coccidioidomycosis in a reference center in Northeast Brazil: Clinical\/epidemiological profile and most common radiological findings","volume":"53","author":"Morais","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lockhart, S.R., Toda, M., Benedict, K., Caceres, D.H., and Litvintseva, A.P. (2021). Endemic and Other Dimorphic Mycoses in The Americas. J. Fungi, 7.","DOI":"10.3390\/jof7020151"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00442634","article-title":"Morphogenesis throughout saprobic and parasitic cycles of Coccidioides immitis","volume":"78","author":"Huppert","year":"1982","journal-title":"Mycopathologia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.00005-13","article-title":"Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis","volume":"26","author":"Nguyen","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1101\/gr.087551.108","article-title":"Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives","volume":"19","author":"Sharpton","year":"2009","journal-title":"Genome Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/mmy\/myy039","article-title":"The endozoan, small-mammal reservoir hypothesis and the life cycle of Coccidioides species","volume":"57","author":"Taylor","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.2460\/javma.2005.226.1846","article-title":"Incidence of coccidioides infection among dogs residing in a region in which the organism is endemic","volume":"226","author":"Shubitz","year":"2005","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1406.007","article-title":"Comparative aspects of coccidioidomycosis in animals and humans","volume":"1111","author":"Shubitz","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wilson, L., Ting, J., Lin, H., Shah, R., MacLean, M., Peterson, M.W., Stockamp, N., Libke, R., and Brown, P. (2019). The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16071113"},{"key":"ref_16","unstructured":"(2013). Increase in reported coccidioidomycosis\u2014United States, 1998\u20132011. MMWR Morb. Mortal. Wkly. Rep., 62, 217\u2013221."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3201\/eid2603.191536","article-title":"Suspected Locally Acquired Coccidioidomycosis in Human, Spokane, Washington, USA","volume":"26","author":"Oltean","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/mmy\/myu004","article-title":"Demonstration of Coccidioides immitis and Coccidioides posadasii DNA in soil samples collected from Dinosaur National Monument, Utah","volume":"52","author":"Johnson","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_19","first-page":"001659","article-title":"Disseminated Coccidioidomycosis in Africa","volume":"7","author":"Yoo","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s40475-019-00184-z","article-title":"Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development","volume":"6","author":"Hernandez","year":"2019","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3201\/eid1811.120752","article-title":"Coccidioidomycosis-associated Deaths, United States, 1990\u20132008","volume":"18","author":"Huang","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3201\/eid1206.060028","article-title":"Coccidioidomycosis as a common cause of community-acquired pneumonia","volume":"12","author":"Valdivia","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jim-2020-001655","article-title":"Coccidioidomycosis: A review","volume":"69","author":"Johnson","year":"2021","journal-title":"J. Investig. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1086\/496991","article-title":"Coccidioidomycosis","volume":"41","author":"Galgiani","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","unstructured":"Johnson, R., Caldwell, J., Welch, G., and Einstein, H. (1996). The great coccidioidomycosis epidemic: Clinical features. Proceedings of the Coccidioidomycosis: Fifth International Conference, National Foundation for Infectious Diseases."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3201\/eid2302.160505","article-title":"Risk Factors for Disseminated Coccidioidomycosis, United States","volume":"23","author":"Odio","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/497596","article-title":"Coccidioidal Meningitis","volume":"42","author":"Goldstein","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/mmy\/myy095","article-title":"Update on the Epidemiology of coccidioidomycosis in the United States","volume":"57","author":"McCotter","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1175\/WCAS-D-20-0036.1","article-title":"Economic Valuation of Coccidioidomycosis (Valley Fever) Projections in the United States in Response to Climate Change","volume":"13","author":"Gorris","year":"2021","journal-title":"Weather Clim. Soc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/jam.15084","article-title":"A global view on fungal infections in humans and animals: Infections caused by dimorphic fungi and dermatophytoses","volume":"131","author":"Gnat","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e01397-19","DOI":"10.1128\/mBio.01397-19","article-title":"On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds","volume":"10","author":"Casadevall","year":"2019","journal-title":"mBio"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11046-020-00431-2","article-title":"Re-drawing the Maps for Endemic Mycoses","volume":"185","author":"Ashraf","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/epirev\/mxz004","article-title":"A Review of Coccidioidomycosis in California: Exploring the Intersection of Land Use, Population Movement, and Climate Change","volume":"41","author":"Pearson","year":"2019","journal-title":"Epidemiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Matlock, M., Hopfer, S., and Ogunseitan, O.A. (2019). Communicating Risk for a Climate-Sensitive Disease: A Case Study of Valley Fever in Central California. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16183254"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jdcr.2017.11.018","article-title":"A case series of primary cutaneous coccidioidomycosis after a record-breaking rainy season","volume":"4","author":"Shiu","year":"2018","journal-title":"JAAD Case Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00484-005-0007-6","article-title":"Climate controls on valley fever incidence in Kern County, California","volume":"50","author":"Zender","year":"2006","journal-title":"Int. J. Biometeorol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jdcr.2017.11.017","article-title":"Disseminated coccidioidomycosis as a harbinger of climate change","volume":"4","author":"Coates","year":"2018","journal-title":"JAAD Case Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1029\/2019GH000209","article-title":"Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change","volume":"3","author":"Gorris","year":"2019","journal-title":"Geohealth"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, J., Harrigan, R.J., and Schoenberg, F.P. (2021). Point Process Models for the Spread of Coccidioidomycosis in California. Infect. Dis. Rep., 13.","DOI":"10.3390\/idr13020052"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e037905","DOI":"10.1136\/bmjopen-2020-037905","article-title":"Retrospective cross-sectional analysis of the changes in marijuana use in the USA, 2005\u20132018","volume":"10","author":"Mitchell","year":"2020","journal-title":"BMJ Open"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jinf.2018.01.010","article-title":"Infectious risks associated with medicinal Cannabis: Potential implications for immunocompromised patients?","volume":"76","author":"McHardy","year":"2018","journal-title":"J. Infect."},{"key":"ref_42","first-page":"bcr-2017","article-title":"Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency","volume":"2018","author":"Hedrick","year":"2018","journal-title":"BMJ Case Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3201\/eid2606.191570","article-title":"Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016","volume":"26","author":"Benedict","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_44","unstructured":"Akram, S.M., and Koirala, J. (2021). Coccidioidomycosis. StatPearls, StatPearls Publishing."},{"key":"ref_45","first-page":"e14151","article-title":"Coccidioidomycosis mimicking testicular cancer: A case report","volume":"53","author":"Soualhi","year":"2021","journal-title":"Andrologia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"ofab266","DOI":"10.1093\/ofid\/ofab266","article-title":"Infected Aneurysm of the Native Aorta due to Coccidioides posadasii","volume":"8","author":"Huang","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_47","first-page":"2324709620974894","article-title":"Disseminated Coccidioidomycosis Presenting as Polyarticular Septic Arthritis: A Case Report","volume":"8","author":"Nasrawi","year":"2020","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_48","first-page":"8025391","article-title":"Coccidioidomycosis of the Vocal Cords Presenting in Sepsis: A Case Report and Literature Review","volume":"2020","author":"Converse","year":"2020","journal-title":"Case Rep. Crit. Care"},{"key":"ref_49","first-page":"8837493","article-title":"Disseminated Coccidioidomycosis Presenting as Septic Shock with Multiorgan Failure","volume":"2021","author":"Aduroja","year":"2021","journal-title":"Case Rep. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e1587","DOI":"10.1093\/cid\/ciaa739","article-title":"Clinician Practice Patterns that Result in the Diagnosis of Coccidioidomycosis Before or During Hospitalization","volume":"73","author":"Pu","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/592073","article-title":"Diagnosis of Coccidioidomycosis with Use of the Coccidioides Antigen Enzyme Immunoassay","volume":"47","author":"Durkin","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1196\/annals.1406.049","article-title":"Laboratory Aspects in the Diagnosis of Coccidioidomycosis","volume":"1111","author":"Saubolle","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/ciaa188","article-title":"Advances in Diagnosis of Progressive Pulmonary and Disseminated Coccidioidomycosis","volume":"72","author":"Kassis","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jom-2020-0081","article-title":"An analysis of research quality underlying IDSA clinical practice guidelines: A cross-sectional study","volume":"121","author":"Greiner","year":"2021","journal-title":"J. Osteopath. Med."},{"key":"ref_56","unstructured":"DIFLUCAN (Fluconazole) (2022, February 24). New York, New York: Pfizer, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/019949s051lbl.pdf."},{"key":"ref_57","unstructured":"Amphotericin, B. (2022, February 24). Big Flats, NY: X-Gen Pharmaceuticals, Inc. Available online: http:\/\/xgenpharmadjb.com\/wp-content\/uploads\/sites\/21\/2021\/12\/ampho.pdf."},{"key":"ref_58","unstructured":"SPORANOX (Itraconazole) (2022, February 24). Raritan, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020083s063lbl.pdf."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/mmy\/myy029","article-title":"Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis","volume":"57","author":"Thompson","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/cid\/cir410","article-title":"Coccidioidomycosis During Pregnancy: A Review and Recommendations for Management","volume":"53","author":"Bercovitch","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dky501","article-title":"Tolerability of long-term fluconazole therapy","volume":"74","author":"Davis","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e02634-02616","DOI":"10.1128\/AAC.02634-16","article-title":"Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions","volume":"61","author":"Thompson","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e01783-01719","DOI":"10.1128\/AAC.01783-19","article-title":"A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation","volume":"64","author":"Decembrino","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11046-010-9324-3","article-title":"Isavuconazole: A comprehensive review of spectrum of activity of a new triazole","volume":"170","author":"Thompson","year":"2010","journal-title":"Mycopathologia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e02232-02218","DOI":"10.1128\/AAC.02232-18","article-title":"Isavuconazole in the Treatment of Coccidioidal Meningitis","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e02344-02320","DOI":"10.1128\/AAC.02344-20","article-title":"Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis","volume":"65","author":"Kovanda","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/mmy\/myab035","article-title":"Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring","volume":"59","author":"Davis","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/mmy\/myy123","article-title":"Coccidioidomycosis: What a long strange trip it\u2019s been","volume":"57","author":"Deresinski","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/jid.1957.26","article-title":"An Evaluation of Amphotericin B In Vitro and In Vivo in Mice Against Coccidioides Immitis and Candida Albicans, and Preliminary Observations Concerning the Administration of Amphotericin B to Man","volume":"28","author":"Halde","year":"1957","journal-title":"J. Investig. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: A comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e02293-02217","DOI":"10.1128\/AAC.02293-17","article-title":"Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis","volume":"62","author":"Sidhu","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e02258-02217","DOI":"10.1128\/AAC.02258-17","article-title":"The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e00999-00918","DOI":"10.1128\/AAC.00999-18","article-title":"The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the Horizon: Novel Fungal Treatments in Development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_76","unstructured":"F2G (2021, August 15). F2G Receives Second US FDA Breakthrough Therapy Designation for Olorofim, Available online: https:\/\/www.prnewswire.com\/news-releases\/f2g-receives-second-us-fda-breakthrough-therapy-designation-for-olorofim-301157698.html."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Jallow, S., and Govender, N.P. (2021). Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor. J. Fungi, 7.","DOI":"10.3390\/jof7030163"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Shaw, K.J., and Ibrahim, A.S. (2020). Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections. J. Fungi, 6.","DOI":"10.3390\/jof6040239"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Larwood, D.J. (2020). Nikkomycin Z\u2014Ready to Meet the Promise?. J. Fungi, 6.","DOI":"10.3390\/jof6040261"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01609-08","article-title":"Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses","volume":"53","author":"Nix","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","article-title":"Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials","volume":"209","author":"Shubitz","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/jac\/dkab223","article-title":"Efficacy of nikkomycin Z in murine CNS coccidioidomycosis: Modelling sustained-release dosing","volume":"76","author":"Sass","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7164\/antibiotics.30.371","article-title":"Ambruticin (W7783), a new antifungal antibiotic","volume":"30","author":"Ringel","year":"1977","journal-title":"J. Antibiot."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.73.2.202","article-title":"Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice","volume":"73","author":"Levine","year":"1978","journal-title":"Chest"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.7164\/antibiotics.53.1182","article-title":"On the mechanism of action of the myxobacterial fungicide ambruticin","volume":"53","author":"Knauth","year":"2000","journal-title":"J. Antibiot."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1128\/AAC.00558-06","article-title":"Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis","volume":"50","author":"Chiang","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/AAC.00670-06","article-title":"Efficacy of ambruticin analogs in a murine model of coccidioidomycosis","volume":"50","author":"Shubitz","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/cmdc.200800008","article-title":"Investigating amine derivatives of ambruticin VS-5 and VS-4","volume":"3","author":"Tian","year":"2008","journal-title":"ChemMedChem"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/AAC.00369-07","article-title":"The Antifungal Polyketide Ambruticin Targets the HOG Pathway","volume":"51","author":"Vetcher","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1128\/AAC.00593-15","article-title":"Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models","volume":"59","author":"Shubitz","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e00111-00117","DOI":"10.1128\/AAC.00111-17","article-title":"Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in Dogs","volume":"61","author":"Shubitz","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"O\u2019Shaughnessy, E., Yasinskaya, Y., Dixon, C., Higgins, K., Moore, J., Reynolds, K., Ampel, N.M., Angulo, D., Blair, J.E., and Catanzaro, A. (2021). FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs. Clin. Infect. Dis., ciab904.","DOI":"10.1093\/cid\/ciab904"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa2000024","article-title":"Disseminated Coccidioidomycosis Treated with Interferon-\u03b3 and Dupilumab","volume":"382","author":"Tsai","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/21501203.2016.1204368","article-title":"Sertraline demonstrates fungicidal activity in vitro for Coccidioides immitis","volume":"7","author":"Paul","year":"2016","journal-title":"Mycology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2011.07.006","article-title":"Two cases illustrating successful adjunctive interferon-\u03b3 immunotherapy in refractory disseminated coccidioidomycosis","volume":"63","author":"Duplessis","year":"2011","journal-title":"J. Infect."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1086\/382075","article-title":"Successful Treatment of a Critically Ill Patient with Disseminated Coccidioidomycosis, Using Adjunctive Interferon-\u03b3","volume":"38","author":"Kuberski","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e00835","DOI":"10.1016\/j.idcr.2020.e00835","article-title":"Interferon-\u03b3 and voriconazole combined therapy for refractory meningeal coccidioidomycosis in a patient with interferon-\u03b3 deficiency","volume":"21","author":"Malek","year":"2020","journal-title":"IDCases"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12969-021-00549-7","article-title":"Disseminated coccidioidomycosis in a patient with juvenile idiopathic arthritis receiving infliximab","volume":"19","author":"Trainor","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kirkland, T.N. (2016). The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas. J. Fungi, 2.","DOI":"10.20944\/preprints201612.0076.v1"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3201\/eid0705.010505","article-title":"Cost-effectiveness of a potential vaccine for Coccidioides immitis","volume":"7","author":"Barnato","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"B R Da Silva, L., P Taborda, C., and D Nosanchuk, J. (2020). Advances in Fungal Peptide Vaccines. J. Fungi, 6.","DOI":"10.3390\/jof6030119"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.74.1.516-527.2006","article-title":"A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1128\/IAI.00961-06","article-title":"Multivalent recombinant protein vaccine against coccidioidomycosis","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1128\/IAI.00566-12","article-title":"Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis","volume":"80","author":"Hurtgen","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/IAI.00070-18","article-title":"Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection","volume":"86","author":"Hung","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"790488","DOI":"10.3389\/fcimb.2021.790488","article-title":"Vaccine Protection of Mice With Primary Immunodeficiencies Against Disseminated Coccidioidomycosis","volume":"11","author":"Powell","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/j.vaccine.2018.04.026","article-title":"Viable spores of Coccidioides posadasii \u0394cps1 are required for vaccination and provide long lasting immunity","volume":"36","author":"Shubitz","year":"2018","journal-title":"Vaccine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2021.10.029","article-title":"\u0394cps1 vaccine protects dogs against experimentally induced coccidioidomycosis","volume":"39","author":"Shubitz","year":"2021","journal-title":"Vaccine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3389\/fimmu.2020.02177","article-title":"Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response","volume":"11","author":"Mercer","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Fr\u00edas-De-Le\u00f3n, M.G., Pinto-Almaz\u00e1n, R., Hern\u00e1ndez-Castro, R., Garc\u00eda-Salazar, E., Meza-Meneses, P., Rodr\u00edguez-Cerdeira, C., Arenas, R., Conde-Cuevas, E., Acosta-Altamirano, G., and Mart\u00ednez-Herrera, E. (2021). Epidemiology of Systemic Mycoses in the COVID-19 Pandemic. J. Fungi, 7.","DOI":"10.3390\/jof7070556"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000509345","article-title":"Avoiding Anchoring Bias in the Times of the Pandemic!","volume":"12","author":"Yousaf","year":"2020","journal-title":"Case Rep. Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Benedict, K., Williams, S., Beekmann, S.E., Polgreen, P.M., Jackson, B.R., and Toda, M. (2021). Testing Practices for Fungal Respiratory Infections and SARS-CoV-2 among Infectious Disease Specialists, United States. J. Fungi, 7.","DOI":"10.3390\/jof7080605"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.riam.2020.07.001","article-title":"Fungal co-infection in COVID-19 patients: Should we be concerned?","volume":"37","author":"Salavert","year":"2020","journal-title":"Rev. Iberoamer. Micol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3201\/eid2705.204661","article-title":"Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020","volume":"27","author":"Heaney","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_115","first-page":"e00163-00121","article-title":"The Brief Case: A Fatal Case of SARS-CoV-2 Coinfection with Coccidioides in Texas\u2014Another Challenge We Face","volume":"59","author":"Nielsen","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_116","first-page":"2324709620972244","article-title":"An Acute Pulmonary Coccidioidomycosis Coinfection in a Patient Presenting With Multifocal Pneumonia With COVID-19","volume":"8","author":"Chang","year":"2020","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"ofab246","DOI":"10.1093\/ofid\/ofab246","article-title":"All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"8","author":"Chen","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_118","first-page":"e15060","article-title":"Cutaneous and Pulmonary Manifestations: COVID-19 Virus or Coccidioidomycosis?","volume":"13","author":"Shah","year":"2021","journal-title":"Cureus"},{"key":"ref_119","first-page":"2324709620930540","article-title":"The Coincidence of 2 Epidemics, Coccidioidomycosis and SARS-CoV-2: A Case Report","volume":"8","author":"Shah","year":"2020","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Zavala, A., and Stark, C.M. (2021). Chest Pain and Fever in a Healthcare Provider During the Global Coronavirus Pandemic. Mil. Med., usab435.","DOI":"10.1093\/milmed\/usab435"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/milmed\/usab132","article-title":"Accelerated Progression of Disseminated Coccidioidomycosis Following SARS-CoV-2 Infection: A Case Report","volume":"186","author":"Krauth","year":"2021","journal-title":"Mil. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"715939","DOI":"10.3389\/fmed.2021.715939","article-title":"Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report","volume":"8","author":"Nassif","year":"2021","journal-title":"Front. Med."},{"key":"ref_123","unstructured":"National Institutes of Health (2021, August 15). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines, Available online: https:\/\/www.covid19treatmentguidelines.nih.gov."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jinf.2013.04.001","article-title":"The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis","volume":"67","author":"Azadeh","year":"2013","journal-title":"J. Infect."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Abdoli, A., Falahi, S., and Kenarkoohi, A. (2021). COVID-19-associated opportunistic infections: A snapshot on the current reports. Clin. Experimentl. Med.","DOI":"10.1007\/s10238-021-00751-7"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis","volume":"324","author":"Group","year":"2020","journal-title":"JAMA"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cpdd.71","article-title":"Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects","volume":"3","author":"Gupta","year":"2014","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Saling, C.F., Gea-Banacloche, J., Trickett, J.S., and Blair, J.E. (2021). Coccidioidomycosis in Allogeneic Stem Cell Transplant Recipients: Case Series and Review of the Literature. J. Fungi, 7.","DOI":"10.3390\/jof7050339"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/INF.0000000000003281","article-title":"Neonatal Coccidioidomycosis: A Single-center Experience and Review of the Literature","volume":"41","author":"Vaughn","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jpids\/piab019","article-title":"Congenital Coccidioidomycosis: A Case Report and Review of the Literature","volume":"10","author":"Naeem","year":"2021","journal-title":"J. Ped. Infect. Dis. Soc."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/4\/413\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:55:33Z","timestamp":1760136933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/4\/413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,17]]},"references-count":130,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["jof8040413"],"URL":"https:\/\/doi.org\/10.3390\/jof8040413","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,17]]}}}